Tumor Antigen by Immunoassay CA 15-3/CA 27.29 – CPT 86300

Date Issued: 7/19/2018

Effective October 30, 2018, EmblemHealth will apply its existing tumor antigen by immunoassay policy to GHI plans. Aligned with a Centers for Medicare & Medicaid Services (CMS) policy, tumor antigen by immunoassay CA 15-3/CA 27.29 (86300) is payable when billed with specific diagnoses (ICD-10-CM codes (C50.011 - C50.929, C79.2, C79.81, G89.3, R97.8, Z85.3)).

CPT 86300 will be denied in the absence of one of the covered diagnoses identified in the National Coverage Determinations (NCD) coding manual.

NCD coding manual Download (PDF)
Our Call Center is currently experiencing extremely high volume and longer wait times. For questions related to COVID-19, visit our COVID-19 FAQs